Language / EN
/ DE ![]()
Bonegrafix products contain bioactive substances to produce ideal graft attributes. These products fall into two categories: (1) solid bone blocks for bone replacement and (2) small powdered or granular substances (with and without inclusion of a cement) for filling defects or holes in bone or stabilizing bone during the healing process.
Bonegrafix is developing bone blocks in standard shapes (e.g., cube, rectangle, or wedge) as well as custom sizes capable of shaping and manipulation by a clinician. Using information obtained from a patient’s anatomical CT scan, clinicians will be able to select the precise skeletal area where bone addition and/or replacement is required.
Bonegrafix can produce a precise bone replacement with optimal surface contact area for maximum tissue regeneration.

In a series of proof-of-concept studies, Bonegrafix has demonstrated production of a bone replacement based on CT data as well as a custom design using computer-aided-design (CAD). This feature would be especially important for plastic or maxillofacial surgeons performing craniofacial reconstruction.
Additional studies indicate significant advantages to Bonegrafix technology, most notably, more rapid new bone formation with greater volume when compared to available options.
Unique to Bonegrafix technology is ambient room temperature processing. As the Company’s manufacturing process does not degrade heat sensitive biologics and/or drugs, it permits direct inclusion to promote rapid bone healing and new bone formation.
Who we are
Our current revenue generating products are in the skin care field. By understanding the natural cellular processes and osmoregulation, our subsidiary company, C’watre, was able to create novel skin care products capable of nourishing the skin in ways otherwise unachievable.
Aug 17, 2009C'watre International, Inc. announces corporate name change to Biomimix, Inc.; ticker symbol becomes BIOM
David Donlin
The Cervelle Group LLC,